Franklin Resources’s Arbutus Biopharma ABUS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-104,423	Closed	-$323K	–	3129
2025 Q2	$323K	Buy	104,423 +11,984	+13%	+$39.8K	﹤0.01%	2537
2025 Q1	$323K	Buy	92,439 +280	+0.3%	+$934	﹤0.01%	2450
2024 Q4	$301K	Buy	+92,159	New	+$339K	﹤0.01%	2499
2023 Q2	–	Sell	-31,436	Closed	-$95.3K	–	2723
2023 Q1	$95.3K	Hold	31,436	–	–	﹤0.01%	2113
2022 Q4	$73.2K	Sell	31,436 -115	-0.4%	-$275	﹤0.01%	2163
2022 Q3	$60K	Buy	31,551 +84	+0.3%	+$198	﹤0.01%	2177
2022 Q2	$85K	Sell	31,467 -14,433	-31%	-$36.9K	﹤0.01%	2177
2022 Q1	$137K	Buy	+45,900	New	+$141K	﹤0.01%	2237
2016 Q1	–	Sell	-1,287,560	Closed	-$5.73M	–	1508
2015 Q4	$5.73M	Sell	1,287,560 -768,740	-37%	-$4.21M	﹤0.01%	1109
2015 Q3	$12.5M	Hold	2,056,300	–	–	0.01%	961
2015 Q2	$24.4M	Buy	2,056,300 +71,400	+4%	+$1.09M	0.01%	844
2015 Q1	$34.7M	Buy	1,984,900 +349,050	+21%	+$7.15M	0.02%	728
2014 Q4	$24.8M	Buy	1,635,850 +589,750	+56%	+$10.2M	0.01%	817
2014 Q3	$22.1M	Sell	1,046,100 -1,225,600	-54%	-$20M	0.01%	843
2014 Q2	$29.7M	Buy	2,271,700 +100,100	+5%	+$1.42M	0.01%	769
2014 Q1	$46.7M	Buy	2,171,600 +149,200	+7%	+$2.68M	0.02%	602
2013 Q4	$16.1M	Buy	+2,022,400	New	+$16.8M	0.01%	873